Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Induction and molecular signature of pathogenic TH17 cells

Nature Immunology volume 13, pages 991–999 (2012)Cite this article

Subjects

Abstract

Interleukin 17 (IL-17)-producing helper T cells (TH17 cells) are often present at the sites of tissue inflammation in autoimmune diseases, which has led to the conclusion that TH17 cells are main drivers of autoimmune tissue injury. However, not all TH17 cells are pathogenic; in fact, TH17 cells generated with transforming growth factor-β1 (TGF-β1) and IL-6 produce IL-17 but do not readily induce autoimmune disease without further exposure to IL-23. Here we found that the production of TGF-β3 by developing TH17 cells was dependent on IL-23, which together with IL-6 induced very pathogenic TH17 cells. Moreover, TGF-β3-induced TH17 cells were functionally and molecularly distinct from TGF-β1-induced TH17 cells and had a molecular signature that defined pathogenic effector TH17 cells in autoimmune disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The induction of TGF-β3 in TH17 cells.
Figure 2: TGF-β3-induced TH17 cells are very pathogenic in inducing autoimmunity.
Figure 3: The pathogenicity of TH17 cells induced with TGF-β3 and IL-6 is very similar to that of TH17 cells induced with IL-1β, IL-6 and IL-23.
Figure 4: Identification of transcriptional signature for pathogenic TH17 cells.
Figure 5: Exogenous TGF-β3 can overcome the absence of T-bet.

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. Szabo, S.J., Sullivan, B.M., Peng, S.L. & Glimcher, L.H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713–758 (2003).

    Article  CAS  PubMed  Google Scholar 

  4. Zheng, W. & Flavell, R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596 (1997).

    Article  CAS  PubMed  Google Scholar 

  5. Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).

    Article  CAS  PubMed  Google Scholar 

  6. Kuchroo, V.K. et al. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20, 101–123 (2002).

    Article  CAS  PubMed  Google Scholar 

  7. Ferber, I.A. et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5–7 (1996).

    CAS  PubMed  Google Scholar 

  8. Wildbaum, G., Youssef, S., Grabie, N. & Karin, N. Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161, 6368–6374 (1998).

    CAS  PubMed  Google Scholar 

  9. Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79–87 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).

    Article  CAS  PubMed  Google Scholar 

  11. Bettelli, E., Korn, T., Oukka, M. & Kuchroo, V.K. Induction and effector functions of TH17 cells. Nature 453, 1051–1057 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).

    Article  CAS  PubMed  Google Scholar 

  13. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).

    Article  CAS  PubMed  Google Scholar 

  14. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485–517 (2009).

    Article  CAS  PubMed  Google Scholar 

  15. Ivanov, I.I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).

    Article  CAS  PubMed  Google Scholar 

  16. Awasthi, A. et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904–5908 (2009).

    Article  CAS  PubMed  Google Scholar 

  17. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).

    Article  CAS  PubMed  Google Scholar 

  18. McGeachy, M.J. et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo. Nat. Immunol. 10, 314–324 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rahman, P. et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58, 1020–1025 (2008).

    Article  CAS  PubMed  Google Scholar 

  21. McGeachy, M.J. et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).

    Article  CAS  PubMed  Google Scholar 

  22. Jäger, A., Dardalhon, V., Sobel, R.A., Bettelli, E. & Kuchroo, V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169–7177 (2009).

    Article  PubMed  Google Scholar 

  23. Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yang, Y. et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206, 1549–1564 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Codarri, L. et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560–567 (2011).

    Article  CAS  PubMed  Google Scholar 

  26. El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568–575 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. McQualter, J.L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873–882 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yang, L.T., Li, W.Y. & Kaartinen, V. Tissue-specific expression of Cre recombinase from the Tgfb3 locus. Genesis 46, 112–118 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lyons, R.M., Miller, D.A., Graycar, J.L., Moses, H.L. & Derynck, R. Differential binding of transforming growth factor-β1, -β2, and -β3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Mol. Endocrinol. 5, 1887–1896 (1991).

    Article  CAS  PubMed  Google Scholar 

  30. Graycar, J.L. et al. Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol. Endocrinol. 3, 1977–1986 (1989).

    Article  CAS  PubMed  Google Scholar 

  31. Veldhoen, M., Hocking, R.J., Flavell, R.A. & Stockinger, B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151–1156 (2006).

    Article  CAS  PubMed  Google Scholar 

  32. Ghoreschi, K. et al. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature 467, 967–971 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. O'Connor, R.A. et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181, 3750–3754 (2008).

    CAS  PubMed  Google Scholar 

  35. Gocke, A.R. et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178, 1341–1348 (2007).

    Article  CAS  PubMed  Google Scholar 

  36. Park, I.K., Shultz, L.D., Letterio, J.J. & Gorham, J.D. TGF-β1 inhibits T-bet induction by IFN-γ in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J. Immunol. 175, 5666–5674 (2005).

    Article  CAS  PubMed  Google Scholar 

  37. Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).

    Article  CAS  PubMed  Google Scholar 

  38. Walline, C.C., Kanakasabai, S. & Bright, J.J. IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun. 12, 1–14 (2011).

    Article  CAS  PubMed  Google Scholar 

  39. Liu, X. et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat. Med. 16, 191–197 (2010).

    Article  CAS  PubMed  Google Scholar 

  40. Lundmark, F. et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39, 1108–1113 (2007).

    Article  CAS  PubMed  Google Scholar 

  41. Gregory, S.G. et al. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39, 1083–1091 (2007).

    Article  CAS  PubMed  Google Scholar 

  42. Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008).

    Article  CAS  PubMed  Google Scholar 

  43. Quintana, F.J. et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65–71 (2008).

    Article  CAS  PubMed  Google Scholar 

  44. Bauquet, A.T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167–175 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854–861 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Zielinski, C.E. et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484, 514–518 (2012).

    Article  CAS  PubMed  Google Scholar 

  47. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380–1389 (2007).

    Article  CAS  PubMed  Google Scholar 

  48. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500–501 (2006).

    Article  CAS  PubMed  Google Scholar 

  49. Irizarry, R.A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).

    Article  PubMed  Google Scholar 

  50. Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank R. Bomireddy (University of Arizona) for mice with loxP-flanked Tgfb3 alleles; and D. Kozoriz for cell sorting. Supported by the US National Institutes of Health (NS030843, NS045937, AI073748 and AI045757 to V.K.K.; AI075285 and AI093903 to F.J.Q.; 1P01HG005062-01 and DP1-OD003958-01 to A.R.; and K01DK090105 to S.X.), the National Multiple Sclerosis Society (RG2571; RG4111A1 to F.J.Q.), the Crohn's and Colitis Foundation of America (A.A.), the Merkin Foundation for Stem Cell Research at the Broad Institute, the National Human Genome Research Institute and the Howard Hughes Medical Institute.

Author information

Author notes

  1. Amit Awasthi

    Present address: Present address: Translational Health Science & Technology Institute, Faridabad, Haryana, India.,

  2. Youjin Lee and Amit Awasthi: These authors contributed equally to this work.

Authors and Affiliations

  1. Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Youjin Lee, Amit Awasthi, Nir Yosef, Francisco J Quintana, Sheng Xiao, Anneli Peters, Chuan Wu, Sharon Kunder & Vijay K Kuchroo

  2. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA

    Nir Yosef & Aviv Regev

  3. Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA

    Markus Kleinewietfeld & David A Hafler

  4. Palo Alto Veteran's Administration Health Care System and Department of Pathology, Stanford University School of Medicine, Stanford, California, USA

    Raymond A Sobel

  5. Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

    Aviv Regev

Authors
  1. Youjin Lee
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Amit Awasthi
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nir Yosef
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Francisco J Quintana
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Sheng Xiao
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Anneli Peters
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Chuan Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Markus Kleinewietfeld
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Sharon Kunder
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. David A Hafler
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Raymond A Sobel
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Aviv Regev
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. Vijay K Kuchroo
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

Y.L. and A.A. designed the study, did experiments, analyzed data and wrote the manuscript; A.P., S.X., S.K., M.K. and C.W. did in vitro experiments; N.Y., F.J.Q. and A.R. did the bioinformatics analysis of gene-expression data; R.A.S. did the immunohistochemical analysis; D.A.H. provided discussions; and V.K.K. and A.A. supervised the study and edited the manuscript.

Corresponding authors

Correspondence to Amit Awasthi or Vijay K Kuchroo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–3 and Table 1 (PDF 1440 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Y., Awasthi, A., Yosef, N. et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13, 991–999 (2012). https://doi.org/10.1038/ni.2416

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.2416

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing